The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis

Cell Growth and Differentiation

Volumn 12, Issue 6, 2001, Pages 297-306

  Chen, C Y ^a   Juo, P ^a   Liou, J S ^a   Li, C Q ^a   Yu, Q ^a   Blenis, J ^a   Faller, D V ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; FAS ANTIGEN; PROTEIN KINASE C; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD95; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARRIER PROTEINS; CASPASE 8; CASPASE 9; CASPASES; CYTOCHROME C GROUP; ENZYME ACTIVATION; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-BCL-2; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 0034920641     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Increasing complexity of Ras signal transduction: Involvement of Rho family proteins
2. Ras effectors and their role in mitogenesis and oncogenesis
3. Ras genes
4. Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway
5. Ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2
6. Ras signaling and apoptosis
7. A matter of life and cell death
8. Ras signaling in tumor necrosis factor-induced apoptosis
9. Differential regulation of discrete apoptotic pathways by Ras
10. Fas or ceramide induce apoptosis by Ras-regulated phosphoinositide-3-kinase activation
11. Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells
12. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte cuclei by agents that stimulate protein kinase C
13. Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression
14. Selective Inhibition of protein kinase C isozymes by Fas ligation
15. Oncogenic Ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species
16. Critical role of ras in the proliferation and prevention of apoptosis mediated by IL-2
17. Ras activation leads to cell proliferation or apoptotic death upon IL-2 stimulation or lymphokine deprivation, respectively
18. Proteases to die for
19. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
20. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
21. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade
22. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
23. FADD is required for multiple signaling events downstream of the receptor Fas
24. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
25. Two CD95 (APO-1/Fas) signaling pathways
26. Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED-3 family proteases
27. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
28. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death
29. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme
30. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
31. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic ras
32. Caspases: Intracellular signaling by proteolysis
33. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
34. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis
35. JNK1: A protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-Jun activation domain
36. JNK is involved in signal integration during costimulation of T lymphocytes
37. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway
38. Lack of a role for jun kinase and AP-1 in Fas-induced apoptosis
39. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
40. Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis
41. The polypeptide endoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
42. The Fas death factor
43. Apoptosis by death factor
44. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interaction
45. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95)receptor/ligand system
46. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs
47. The extracellular matrix as a cell survival factor
48. Disruption of epithelial cell-matrix interactions induces apoptosis
49. Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis
50. Involvement of FADD and caspase-8 signaling in detachment-induced apoptosis
51. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis
52. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
53. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
54. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line
55. Use of a selectable marker regulated by α interferon to obtain mutations in the signaling pathway
56. Isolation and characterization of a new mutant human cell line unresponsive to α and β interferons